XXEC Inc. Increases Holdings in Proto Labs, Inc. $PRLB

XXEC Inc. boosted its stake in shares of Proto Labs, Inc. (NYSE:PRLB) by 2,060.4% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,261,547 shares of the industrial products company’s stock after acquiring an additional 1,203,154 shares during the quarter. Proto Labs accounts for 55.7% of XXEC Inc.’s portfolio, making the stock its largest position. XXEC Inc. owned about 0.05% of Proto Labs worth $111,461,682,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors also recently made changes to their positions in PRLB. Royal Bank of Canada boosted its stake in shares of Proto Labs by 51.3% in the 1st quarter. Royal Bank of Canada now owns 6,510 shares of the industrial products company’s stock valued at $228,000 after purchasing an additional 2,207 shares in the last quarter. AQR Capital Management LLC increased its position in shares of Proto Labs by 3.3% during the 1st quarter. AQR Capital Management LLC now owns 63,871 shares of the industrial products company’s stock worth $2,238,000 after purchasing an additional 2,040 shares in the last quarter. NewEdge Advisors LLC increased its position in shares of Proto Labs by 7,380.0% during the 1st quarter. NewEdge Advisors LLC now owns 748 shares of the industrial products company’s stock worth $26,000 after purchasing an additional 738 shares in the last quarter. JPMorgan Chase & Co. lifted its holdings in Proto Labs by 68.8% during the 2nd quarter. JPMorgan Chase & Co. now owns 21,756 shares of the industrial products company’s stock valued at $871,000 after purchasing an additional 8,864 shares during the last quarter. Finally, Hsbc Holdings PLC bought a new position in Proto Labs during the 2nd quarter valued at about $480,000. 84.54% of the stock is owned by institutional investors.

Proto Labs Stock Performance

Shares of NYSE:PRLB opened at $79.48 on Friday. Proto Labs, Inc. has a twelve month low of $45.10 and a twelve month high of $93.00. The firm has a market cap of $1.90 billion, a PE ratio of 63.58 and a beta of 1.40. The business has a fifty day moving average of $80.56 and a 200-day moving average of $70.19.

Proto Labs (NYSE:PRLB) last issued its quarterly earnings results on Friday, July 31st. The industrial products company reported $0.60 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.53 by $0.07. Proto Labs had a net margin of 5.44% and a return on equity of 4.80%. The business had revenue of $149.34 million for the quarter, compared to the consensus estimate of $144.53 million. During the same quarter in the prior year, the company earned $0.41 EPS. The firm’s quarterly revenue was up 10.5% on a year-over-year basis. Proto Labs has set its Q3 2026 guidance at 0.560-0.640 EPS. On average, analysts anticipate that Proto Labs, Inc. will post 1.46 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on the stock. Zacks Research upgraded shares of Proto Labs from a “hold” rating to a “strong-buy” rating in a research report on Thursday, August 6th. Wall Street Zen lowered shares of Proto Labs from a “strong-buy” rating to a “buy” rating in a report on Saturday, July 18th. Benchmark lifted their target price on shares of Proto Labs from $70.00 to $91.00 and gave the company a “buy” rating in a research note on Thursday, July 2nd. Weiss Ratings downgraded Proto Labs from a “buy (b)” rating to a “buy (b-)” rating in a report on Tuesday. Finally, Needham & Company LLC raised Proto Labs from a “hold” rating to a “buy” rating and set a $87.00 target price on the stock in a report on Monday, August 3rd. One research analyst has rated the stock with a Strong Buy rating and three have assigned a Buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Buy” and an average target price of $89.00.

Insider Buying and Selling at Proto Labs

In other Proto Labs news, Director Sven Wehrwein sold 2,000 shares of the business’s stock in a transaction dated Tuesday, June 2nd. The shares were sold at an average price of $77.28, for a total value of $154,560.00. Following the completion of the transaction, the director directly owned 32,505 shares of the company’s stock, valued at approximately $2,511,986.40. The trade was a 5.80% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 1.30% of the company’s stock.

About Proto Labs

Proto Labs, Inc is a digital manufacturing company that offers on-demand production services for custom parts and prototypes. Utilizing technologies such as 3D printing (additive manufacturing), CNC machining and injection molding, the company transforms digital CAD designs into functional parts on accelerated timelines. Its platform-driven process combines automated quoting, rapid tool generation and manufacturing execution to serve product developers, engineers and small- to medium-sized production runs.

Founded in 1999 by Larry Lukis, Proto Labs has championed the application of digital workflows to traditional manufacturing methods.